GeneralConnection.com ➔ Dictionary
Dictionary Search

polycythemia

Synonyms

Noun

1. blood disease

2. blood disorder

Usage
Dr Vachhani on Phase 2 Efficacy/Safety Data for Sapablursen in Polycythemia Vera - OncLive
FDA Clears Pen Device for Interferon Therapy in Polycythemia Vera - Targeted Oncology
FDA Approves BESREMi Pen for Self-Administration in Polycythemia Vera - Oncology Nursing News
Polycythemia Vera Prevalence to Near 100K by 2030 as Symptom Burden Grows - AJMC
Optimized post-GWAS analysis identifies therapeutic targets for essential thrombocythemia and polycythemia vera - Nature
Interferons in Polycythemia Vera Management - HMP Global Learning Network
PharmaEssentia Announces FDA Approval and U.S. Launch of BESREMi Pen™ (ropeginterferon alfa-2b-njft) for Polycythemia Vera - Business Wire
Polycythemia Vera: JAK2 Inhibitor Patient Selection - Targeted Oncology
Retroperitoneal and Pelvic Myeloid Sarcoma in a Patient With JAK2-Positive Polycythemia Vera: A Case Report - Cureus
HbA1c May Underestimate Glycemic Control in Patients With Polycythemia: Study - Medical Dialogues
FDA Approves Prefilled Pen for Ropeginterferon Alfa-2b in Polycythemia Vera - OncLive
How Silence Therapeutics (SLN) Is Building the Divesiran Case Around Fewer Blood Draws in Polycythemia Vera - Yahoo Finance
Potential Rusfertide Approval May Offer More Control of Polycythemia Vera - CancerNetwork
Deciphera Pharmaceuticals Announces First Patient Dosed in Pivotal Phase 3 INTREPID Study of Sapablursen in Polycythemia Vera - BioSpace
FDA Grants Priority Review to Rusfertide for Polycythemia Vera - Cure Today
Phlebotomy Burden Undermines Consistent PV Control - AJMC
Emerging Evidence for Earlier Intervention in Low-Risk Polycythemia Vera - Targeted Oncology
Impact of thrombosis on disease progression, cancer and mortality in patients with essential thrombocythemia and polycythemia vera - Nature
Optimizing Treatment Outcomes in Polycythemia Vera - Targeted Oncology
Considerations in the First-Line Setting in Polycythemia Vera - Targeted Oncology
LLM Tool Significantly Reduces Participant Screening Burdens, Improves Enrollment for Phase III Trial in Polycythemia Vera - The ASCO Post
Hepcidin Modulation in Polycythemia Vera: Current Landscape and Next Steps - ASCO Daily News
Revisiting old drugs and drug combinations for polycythemia vera and related neoplasms - Frontiers
Jakafi XR Approved for Myelofibrosis, Polycythemia Vera, and GVHD - MPR - Medical Professionals Reference
Rusfertide May Become Part of Polycythemia Vera Armamentarium - CancerNetwork
Rusfertide Earns FDA Priority Review in Polycythemia Vera - CancerNetwork
Navigating Resistance and Intolerance in High-Risk Polycythemia Vera - Targeted Oncology
Hepcidin Mimetic Rusfertide Gets Priority Review for Polycythemia Vera - Hematology Advisor
Polycythemia Vera Market Set for Transformation: Key 9 Companies Expected to Enter by 2036 | DelveInsight - Yahoo Finance
Does Ono’s Phase 3 Sapablursen Trial in Polycythemia Vera Reshape The Bull Case For Ono Pharmaceutical (TSE:4528)? - simplywall.st
FDA Clears Once-Daily Ruxolitinib Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - OncLive
FDA Approves Ruxolitinib Extended-Release Tablets for Myelofibrosis, Polycythemia Vera, and GVHD - Docwire News
Sequential Transformation of Polycythemia Vera to Myelofibrosis and KMT2A-Rearranged Acute Myeloid Leukemia Treated With Revumenib: A Rare Case of Clonal Evolution - Cureus
FDA approves BESREMi Pen for polycythemia vera treatment By Investing.com - Investing.com Nigeria
Novartis Korea's Jakavi wins reimbursement for 2nd-line treatment of polycythemia vera - koreabiomed.com
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera - PR Newswire
FDA Accepts New Drug Application for Rusfertide, Grants Priority Review In Polycythemia Vera - HCPLive
FDA Grants Priority Review to Rusfertide in Polycythemia Vera - OncLive
Silence Therapeutics Highlights Follow-Up Data at EHA 2026 Demonstrating Durable Efficacy and Potential Best-in-Class Profile for Divesiran in Polycythemia Vera - Business Wire
Rusfertide Approval Would Move Past ‘Archaic’ Polycythemia Vera Standard - CancerNetwork
Autoimmune and Inflammatory Diseases in Polycythemia Vera and Essential Thrombocythemia: Impact on Disease Outcomes and Comorbidities - Wiley Online Library
Polycythemia vera: Phlebotomy remains high-burden and often insufficient in real-world care - Vera Health
AN2 Therapeutics Announces Plans to Advance Oral Epetraborole into Phase 2 Study for Polycythemia Vera (PV) - BioSpace
Cardioembolic ST-Elevation Myocardial Infarction in a Patient With Atrial Fibrillation and Polycythemia Vera - Cureus
GLP-1a Therapy Improves Survival in Patients with Polycythemia Vera and Myelodysplastic Syndromes - Cleveland Clinic
Oncology Drugs Fast-Tracked and Prioritized by the FDA in March 2026 - Oncology News Central
Polycythemia vera: High-dose rapid titration of ropeginterferon speeds early responses - Vera Health
Polycythemia vera and essential thrombocythemia: Identify patients at highest risk for fibrotic progression - Vera Health
The use of ropeginterferon alpha-2b in the treatment of polycythemia vera in a young patient with joint pain - Via Medica Journals
Incyte Announces FDA Approval of Jakafi XR™ (ruxolitinib) Extended-Release Tablets for the Treatment of Myelofibrosis, Polycythemia Vera and Graft-Versus-Host Disease - Yahoo Finance
Takeda And Protagonist Secure FDA Priority Review For Rusfertide In Polycythemia Vera - BioPharma APAC
Polycythemia Vera and Essential Thrombocythemia: A Nationwide Population‐Based Study on Treatment Patterns, Vascular Complications and Survival - Larsson - 2026 - European Journal of Haematology - Wiley Online Library
Developers Submit NDA to FDA for Rusfertide in Polycythemia Vera - CancerNetwork
When the Air Gets Thin, and the Blood Gets Thick: Choroidal Hemangioma in High-Altitude Polycythemia - Cureus
FDA Application Submitted for Rusfertide Treatment in Polycythemia Vera - Cure Today
Does Polycythemia Vera Cause Erectile Dysfunction? - Portal CNJ
What Blood Cancer Does Anna Have On GH? Her Polycythemia Vera Explained - Soap Opera Digest
Takeda and Protagonist Announce U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Rusfertide as a Potential First-in-Class Therapy for Polycythemia Vera - Via TT
What Fatigue Feels Like for a Patient With Polycythemia Vera - Cure Today
Rusfertide Maintains Hematocrit Control in Patients With Polycythemia Vera - Cure Today
Phase 2 Trial Begins for First-in-Class Polycythemia Vera Treatment - Docwire News
GLP-1 Therapy Linked to Improved Outcomes in Polycythemia Vera - Cure Today
JAK Inhibitors Expand Treatment Options in Polycythemia Vera and Myelofibrosis - OncLive
SANRECO Trial Explores Divesiran for Polycythemia Vera Treatment - Cure Today
Low neutrophil-to-lymphocyte ratio identifies secondary polycythemia in patients with erythrocytosis - Nature
Aaron Gerds, MD, on Using an AI System to Identify Patients Eligible for a Polycythemia Vera Trial - The ASCO Post
Dr Desai on the Treatment Landscape of Polycythemia Vera - OncLive
Weekly injection a potential new treatment option for polycythemia vera - Wiley & Sons
Rusfertide Continues to Show Strong Results for Polycythemia Vera - OncLive
Key Link Found in Ropeginterferon Treatment for Polycythemia Vera - Docwire News
Breaking Down the Standard of Care for Patients With Polycythemia Vera - Cure Today
NDA Submitted to FDA for Rusfertide for Polycythemia Vera - OncLive
FDA Grants Breakthrough Therapy Designation to Rusfertide for Erythrocytosis in Polycythemia Vera - OncLive
GLP-1 Agonists Show Therapeutic Benefits in Polycythemia Vera Population - CancerNetwork
Treating Low-Risk Polycythemia Vera in the Second Line - Targeted Oncology
ASH: Merck mulls future of polycythemia program while Takeda takes phase 3 victory lap - Fierce Biotech
Weight-Loss Drugs for Polycythemia Vera? - Medscape
AI Screening Platform Accelerates Trial Recruitment in Polycythemia Vera - Cleveland Clinic
Rampal Analyzes Ropeginterferon Data in Low-Risk Polycythemia Vera - Targeted Oncology
Rusfertide Earns FDA BTD for Erythrocytosis in Polycythemia Vera - CancerNetwork
Dr Kuykendall on Quality of Life Outcomes With Rusfertide in Polycythemia Vera - OncLive
Dr Jain on Persisting Gaps in Defining Disease Modification in Polycythemia Vera and Myelofibrosis - OncLive
Rusfertide Earns Breakthrough Therapy Designation in Polycythemia Vera - Cure Today
Rusfertide Cuts Number of Needed Blood Draws to Treat PCV - National Cancer Institute (.gov)
Dr Jain on the Role of Ruxolitinib in Polycythemia Vera and Myelofibrosis - OncLive
Considerations for Selection and Sequencing in Polycythemia Vera and Myelofibrosis - OncLive
A molecular signature predicts hematologic evolution in polycythemia vera patients | Leukemia - Nature
Divesiran Shows Promise as RNA-Based Approach in Polycythemia Vera - OncLive
High altitude polycythemia and its maladaptive mechanisms: an updated review - Frontiers
New Therapies Advance for Rare Blood Cancer Polycythemia Vera - Cure Today
Dr Kremyanskaya on the Ongoing Development of Divesiran for Polycythemia Vera - OncLive
Polycythemia: How too much blood can put you at risk - standardmedia.co.ke
When Rusfertide May Become Accessible for Those with Polycythemia Vera - Cure Today
Takeda and Protagonist Announce Submission of Rusfertide NDA for Polycythemia Vera - HCPLive
Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera - The New England Journal of Medicine
Addressing the Hidden Burden of Polycythemia Vera: Andrew Kuykendall, MD - AJMC
FDA Gives Fast Track Designation to Givinostat for Polycythemia Vera - CancerNetwork
The Evolving Landscape of Polycythemia Vera Treatment - Pharmacy Times – Pharmacy Practice News and Expert Insights
Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera - PR Newswire
VERIFY: Novel Polycythemia Vera Treatment Reduces Disease Burden, Improves Quality of Life in Patients With Phlebotomy-Dependent Disease - ASCO Daily News
Foreign Language Equivalents
Foreign Language Equivalents of 'polycythemia'
Language Equivalent   Language Equivalent
French    Spanish
Misspellings - Typos
polyxythemia,   oplycythemia,   poylcythemia,   polycyythemia,   polycuthemia,   polycythema,   poolycythemia,   polyycythemia,   ppolycythemia,   olycythemia,   polycytthemia,   polyythemia,   oolycythemia,   pilycythemia,   polyccythemia,   polycythemai,   poltcythemia,   polycyhtemia,   polyycthemia,   polycthemia,   polycythemi,   polcythemia,   polycythemua,   polycythemiia,   polyctyhemia,   polycytehmia,   polycytemia,   po;ycythemia,   polycytheima,   polycythe,ia,   polycythmia,   polycythemoa,   polucythemia,   ploycythemia,   polycythhemia,   [olycythemia,   polycyrhemia,   plycythemia,   polycythrmia,   polycytheia,   polycytgemia,   polyvythemia,   polycyhemia,   polycythmeia,   poycythemia,   polycytjemia,   polcyythemia,   polycythemmia,   polyctthemia,   polycythemiaa,   polycytheemia,   pokycythemia,   pollycythemia,   polycythenia,   polycythemis,   polycythwmia,   pplycythemia,   polycyyhemia
Words Starting with Letter - 'A'
a a battery a billion
a bit a bit much a capella singing
a cappella singing a couple of a few
a fortiori a good deal a great deal
a horizon a hundred a hundred and one
a hundred thousand a hundred times a kempis
a la carte a la mode a level
a little a lot a million
Go to Page 1              Go to Page 2 »   
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z